-
EP3481374
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3481374
| EP3481374 - DESENSITIZING MAST CELLS BY CO-PRESENTATION OF ANTIGENS WITH HIGH AFFINITY MAST CELL SIGLEC LIGANDS [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 18.03.2022 Database last updated on 24.08.2024 | |
| Former | Request for examination was made Status updated on 12.04.2019 | ||
| Former | The international publication has been made Status updated on 12.01.2018 | ||
| Former | unknown Status updated on 04.08.2017 | Most recent event Tooltip | 12.06.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states The Scripps Research Institute 10550 North Torrey Pines Road La Jolla, CA 92037 / US | [2019/20] | Inventor(s) | 01 /
PAULSON, James C. 14024 Rue Saint Tropez Del Mar, California 92014 / US | 02 /
DUAN, Shiteng 7130 Shoreline Drive Unit 1104 San Diego, California 92122 / US | 03 /
MACAULEY, Matthew 6038 107a St, NW Edmonton Alberta T6H 2Y5 / CA | 04 /
NYCHOLAT, Corwin 3755 Carmel View Road Unit 5 San Diego, California 92130 / US | [2019/37] |
| Former [2019/20] | 01 /
PAULSON, James C. 14024 Rue Saint Tropez Del Mar, California 92014 / US | ||
| 02 /
DUAN, Shiteng 7130 Shoreline Drive Unit 1104 San Diego, California 92122 / US | |||
| 03 /
MACAULEY, Matthew 8696 Lynx Road San Diego, California 92126 / US | |||
| 04 /
NYCHOLAT, Corwin 3755 Carmel View Road Unit 5 San Diego, California 92130 / US | Representative(s) | Murgitroyd & Company 165-169 Scotland Street Glasgow G5 8PL / GB | [N/P] |
| Former [2019/20] | Schwegman Lundberg Woessner Limited Hillington Park Innovation Centre 1 Ainslie Road Glasgow G52 4RU / GB | Application number, filing date | 17743429.7 | 07.07.2017 | [2019/20] | WO2017US41138 | Priority number, date | US201662359762P | 08.07.2016 Original published format: US 201662359762 P | [2019/20] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018009825 | Date: | 11.01.2018 | Language: | EN | [2018/02] | Type: | A1 Application with search report | No.: | EP3481374 | Date: | 15.05.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 11.01.2018 takes the place of the publication of the European patent application. | [2019/20] | Search report(s) | International search report - published on: | EP | 11.01.2018 | Classification | IPC: | A61K9/127, A61K49/00, A61K31/715, A61P37/08 | [2019/20] | CPC: |
A61K9/1271 (EP,US);
A61K39/385 (US);
A61K31/702 (EP,US);
A61K31/7028 (EP,US);
A61K31/7056 (EP,US);
A61K39/39566 (US);
A61K45/06 (EP,US);
A61K47/6911 (US);
A61K49/0084 (EP,US);
| C-Set: |
A61K31/7028, A61K2300/00 (EP,US);
A61K31/7056, A61K2300/00 (US,EP) | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/20] | Title | German: | DESENSIBILISIERUNG VON MASTZELLEN DURCH CO-PRÄSENTATION VON ANTIGENEN MIT HOCHAFFINEN MASTZELLEN-SIGLEC-LIGANDEN | [2019/20] | English: | DESENSITIZING MAST CELLS BY CO-PRESENTATION OF ANTIGENS WITH HIGH AFFINITY MAST CELL SIGLEC LIGANDS | [2019/20] | French: | DÉSENSIBILISATION DE MASTOCYTES PAR CO-PRÉSENTATION D'ANTIGÈNES AVEC DES LIGANDS DE SIGLEC À MASTOCYTES À HAUTE AFFINITÉ | [2019/20] | Entry into regional phase | 07.01.2019 | National basic fee paid | 07.01.2019 | Designation fee(s) paid | 07.01.2019 | Examination fee paid | Examination procedure | 07.01.2019 | Examination requested [2019/20] | 07.01.2019 | Date on which the examining division has become responsible | 11.09.2019 | Amendment by applicant (claims and/or description) | 22.03.2022 | Despatch of a communication from the examining division (Time limit: M04) | 27.07.2022 | Reply to a communication from the examining division | 02.01.2024 | Despatch of a communication from the examining division (Time limit: M06) | 30.05.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 15.07.2019 | Renewal fee patent year 03 | 14.07.2020 | Renewal fee patent year 04 | 15.07.2021 | Renewal fee patent year 05 | 28.06.2022 | Renewal fee patent year 06 | 14.06.2023 | Renewal fee patent year 07 | 12.06.2024 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]WO2007056525 (PAULSON JAMES [US], et al) [X] 1-6,12,15,16,18,21,22 * page 64 - page 65 *; | [X]WO2012018377 (SCRIPPS RESEARCH INST [US], et al) [X] 1-6,12,15,16,18,21,22 * examples 2,3 *; | [Y]WO2014188423 (YISSUM RES DEV CO [IL]) [Y] 1-29* examples 1-3 *; | [X] - MATTHEW S. MACAULEY ET AL, "Antigenic liposomes displaying CD22 ligands induce antigen-specific B cell apoptosis", JOURNAL OF CLINICAL INVESTIGATION, (20130701), vol. 123, no. 7, doi:10.1172/JCI69187, ISSN 0021-9738, pages 3074 - 3083, XP055098288 [X] 1-6,12,15,16,18,21,22 * page 2 - page 4 * * figure 1 * DOI: http://dx.doi.org/10.1172/JCI69187 | [X] - WEIHSU C. CHEN ET AL, "Antigen Delivery to Macrophages Using Liposomal Nanoparticles Targeting Sialoadhesin/CD169", PLOS ONE, (20120619), vol. 7, no. 6, doi:10.1371/journal.pone.0039039, page e39039, XP055098405 [X] 1-6,12,15,16,18,21,22 * page 4 * DOI: http://dx.doi.org/10.1371/journal.pone.0039039 | [X] - CORY D. RILLAHAN ET AL, "Disubstituted sialic acid ligands targeting siglecs CD33 and CD22 associated with myeloid leukaemias and B cell lymphomas", CHEMICAL SCIENCE, United Kingdom, (20140101), vol. 5, no. 6, doi:10.1039/c4sc00451e, ISSN 2041-6520, page 2398, XP055405201 [X] 7-11 * page 2401 - page 2405 * DOI: http://dx.doi.org/10.1039/c4sc00451e | [Y] - KIWAMOTO TAKUMI ET AL, "Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions", PHARMACOLOGY AND THERAPEUTICS, (20120901), vol. 135, no. 3, doi:10.1016/J.PHARMTHERA.2012.06.005, ISSN 0163-7258, pages 327 - 336, XP028932703 [Y] 1-29 * the whole document * DOI: http://dx.doi.org/10.1016/j.pharmthera.2012.06.005 | by applicant | US3561444 | US3703173 | US4051842 | US4140122 | US4383529 | US4624251 | US4635627 | US4962091 | WO9407529 | WO2007056525 | WO2012018377 | - BOCHNER et al., J. Biol. Chem., (20050000), vol. 280, pages 4307 - 12 | - FLOYD et al., J. Biol. Chem., (20000000), vol. 275, pages 861 - 66 | - NEWMAN, S. P., Aerosols and the Lung, Butterworths, (19840000), pages 197 - 224 | - RILLAHAN et al., Angew. Chem., Int. Ed. Engl., (20120000), vol. 51, pages 11014 - 11018 | - BLIXT et al., J. Am. Chem. Soc., (20080000), vol. 130, pages 6680 - 6681 | - BLIXT et al., Proc. Nαtl. Acad. Sci. U. S. A., (20040000), vol. 101, pages 17033 - 17038 | - BLIXT et al., J. Biol. Chem., (20030000), vol. 278, pages 31007 - 31019 | - BLIXT et al., Proc. Nail. Acad. Sci. U. S. A., (20040000), vol. 101, pages 17033 - 17038 | - MACAULEY, M. S.; CROCKER, P. R.; PAULSON, J. C., Nat Rev Immunol, (20140000), vol. 14, no. 10, pages 653 - 66 | - CROCKER, P. R.; PAULSON, J. C.; VARKI, A., Nat Rev Immunol, (20070000), vol. 7, no. 4, pages 255 - 66 | - RILLAHAN, C. D.; SCHWARTZ, E.; RADEMACHER, C.; MCBRIDE, R.; RANGARAJAN, J.; FOKIN, V. V.; PAULSON, J. C., ACS Chem Biol, (20130000), vol. 8, no. 7, pages 1417 - 22 | - RILLAHAN, C. D.; SCHWARTZ, E.; MCBRIDE, R.; FOKIN, V. V.; PAULSON, J. C., Angew Chem Int Ed Eng, (20120000), vol. 51, no. 44, pages 11014 - 8 | - RILLAHAN, C. D.; MACAULEY, M. S.; SCHWARTZ, E.; HE, Y.; MCBRIDE, R.; ARLIAN, B. M.; RANGARAJAN, J.; FOKIN, V. V.; PAULSON, J. C., Chem Sci, (20140000), vol. 5, no. 6, pages 2398 - 2406 | - NYCHOLAT, C. M.; RADEMACHER, C.; KAWASAKI, N.; PAULSON, J. C., J Am Chem Soc, (20120000), vol. 134, no. 38, pages 15696 - 9 | - BULL, C.; HEISE, T.; ADEMA, G. J.; BOLTJE, T. J., Trends Biochem Sci, (20160000), vol. 41, no. 6, pages 519 - 31 | - BULL, C.; HEISE, T.; VAN HILTEN, N.; PIJNENBORG, J. F.; BLOEMENDAL, V. R.; GERRITS, L.; KERS-REBEL, E. D.; RITSCHEL, T.; DEN BROK,, Angew Chem Int Ed Engl, (20170000), vol. 56, no. 12, pages 3309 - 3313 | - YU, W.; FREELAND, D. M.; NADEAU, K. C., Nat Rev Immunol, (20160000), vol. 16, no. 12, pages 751 - 765 | - SICHERER, S. H.; SAMPSON, H. A., J Allergy Clin Immunol, (20140000), vol. 133, no. 2, pages 291 - 307 |